Living-donor or deceased-donor liver transplantation for hepatic carcinoma: A case-matched comparison

Table 3 Perioperative outcomes and oncological characteristics n (%)

Variable	LDLT ( n= 40)	DDLT (n = 80)	P value
Duration of operation (min)	553 ± 105	445 ± 75	< 0.001
Estimated blood loss (mL)	1188 ± 824	1035 ± 1072	0.055
Intraoperative transfusion	24 (60.0)	35 (43.8)	0.093
Tumor pathological type			0.557
HCC	39 (97.5)	79 (98.8)
ICC	0	1 (1.3)
cHCC-CC	1 (2.5)	0
Tumor size (cm)	3.8 ± 1.9	4.1 ± 2.3	0.708
Tumor number			0.238
Single	27 (67.5)	62 (77.5)
Multiple	13 (32.5)	18 (22.5)
Vascular invasion	3 (7.5)	4 (5.0)	0.890
Within Milan criteria	24 (60.0)	48 (60.0)	> 0.999
Outside Milan criteria (Pittsburgh staging)			> 0.999
I	12 (30.0)	24 (30.0)
IVa	2 (5.0)	4 (5.0)
IVb	2 (5.0)	4 (5.0)

Data are expressed as absolute mean ± SD or numbers (percentage). LDLT: Living-donor liver transplantation; DDLT: Deceased-donor liver transplantation; HCC: Hepatocellular carcinoma; ICC: Intrahepatic cholangiocarcinoma; cHCC-CC: Combined hepatocellular carcinoma and cholangiocarcinoma.